A.R.T. Advisors, LLC - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 84 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2019$577,000
+42.5%
22,290
+7.2%
0.03%
+40.0%
Q3 2019$405,000
+5.5%
20,790
+38.6%
0.02%
-20.0%
Q4 2018$384,000
+14.3%
15,005
+45.6%
0.02%
+66.7%
Q3 2018$336,000
+9.4%
10,306
-24.0%
0.02%
+25.0%
Q2 2018$307,000
-55.8%
13,561
-74.6%
0.01%
-47.8%
Q2 2015$694,000
-22.3%
53,379
-10.9%
0.02%
-30.3%
Q4 2014$893,00059,8850.03%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders